Your browser doesn't support javascript.
loading
Rituximab in myasthenia gravis: efficacy, associated infections and risk of induced hypogammaglobulinemia.
Caballero-Ávila, Marta; Álvarez-Velasco, Rodrigo; Moga, Esther; Rojas-Garcia, Ricard; Turon-Sans, Janina; Querol, Luis; Olivé, Montse; Reyes-Leiva, David; Illa, Isabel; Gallardo, Eduard; Cortés-Vicente, Elena.
Affiliation
  • Caballero-Ávila M; Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau; Department of Medicine, Universitat Autònoma de Barcelona; and Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER)
  • Álvarez-Velasco R; Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau; Department of Medicine, Universitat Autònoma de Barcelona; and Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER)
  • Moga E; Department of Immunology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Rojas-Garcia R; Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau; Department of Medicine, Universitat Autònoma de Barcelona; and Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER)
  • Turon-Sans J; Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau; Department of Medicine, Universitat Autònoma de Barcelona; and Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER)
  • Querol L; Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau; Department of Medicine, Universitat Autònoma de Barcelona; and Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER)
  • Olivé M; Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau; Department of Medicine, Universitat Autònoma de Barcelona; and Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER)
  • Reyes-Leiva D; Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau; Department of Medicine, Universitat Autònoma de Barcelona; and Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER)
  • Illa I; Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau; Department of Medicine, Universitat Autònoma de Barcelona; and Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER)
  • Gallardo E; Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau; Department of Medicine, Universitat Autònoma de Barcelona; and Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER)
  • Cortés-Vicente E; Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau; Department of Medicine, Universitat Autònoma de Barcelona; and Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER)
Neuromuscul Disord ; 32(8): 664-671, 2022 08.
Article in En | MEDLINE | ID: mdl-35811274

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Agammaglobulinemia / Myasthenia Gravis Type of study: Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Neuromuscul Disord Journal subject: NEUROLOGIA Year: 2022 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Agammaglobulinemia / Myasthenia Gravis Type of study: Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Neuromuscul Disord Journal subject: NEUROLOGIA Year: 2022 Type: Article